Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab

NCT00588900 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: cediranib maleate
DRUG: irinotecan hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]